These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28108216)

  • 1. The phenomenon of atherosclerosis reversal and regression: Lessons from animal models.
    Chistiakov DA; Myasoedova VA; Revin VV; Orekhov AN; Bobryshev YV
    Exp Mol Pathol; 2017 Feb; 102(1):138-145. PubMed ID: 28108216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.
    Liang SJ; Zeng DY; Mai XY; Shang JY; Wu QQ; Yuan JN; Yu BX; Zhou P; Zhang FR; Liu YY; Lv XF; Liu J; Ou JS; Qian JS; Zhou JG
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):618-28. PubMed ID: 26916730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Effects of Diet-Induced Lipid Lowering Versus Lipid Lowering Along With Apo A-I Milano Gene Therapy on Regression of Atherosclerosis.
    Wang L; Tian F; Arias A; Yang M; Sharifi BG; Shah PK
    J Cardiovasc Pharmacol Ther; 2016 May; 21(3):320-8. PubMed ID: 26499098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of macrophage proliferation dominates plaque regression in response to cholesterol lowering.
    Härdtner C; Kornemann J; Krebs K; Ehlert CA; Jander A; Zou J; Starz C; Rauterberg S; Sharipova D; Dufner B; Hoppe N; Dederichs TS; Willecke F; Stachon P; Heidt T; Wolf D; von Zur Mühlen C; Madl J; Kohl P; Kaeser R; Boettler T; Pieterman EJ; Princen HMG; Ho-Tin-Noé B; Swirski FK; Robbins CS; Bode C; Zirlik A; Hilgendorf I
    Basic Res Cardiol; 2020 Dec; 115(6):78. PubMed ID: 33296022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein AI) Promotes Atherosclerosis Regression in Diabetic Mice by Suppressing Myelopoiesis and Plaque Inflammation.
    Barrett TJ; Distel E; Murphy AJ; Hu J; Garshick MS; Ogando Y; Liu J; Vaisar T; Heinecke JW; Berger JS; Goldberg IJ; Fisher EA
    Circulation; 2019 Oct; 140(14):1170-1184. PubMed ID: 31567014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
    Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
    Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD70 limits atherosclerosis and promotes macrophage function.
    Winkels H; Meiler S; Smeets E; Lievens D; Engel D; Spitz C; Bürger C; Rinne P; Beckers L; Dandl A; Reim S; Ahmadsei M; Van den Bossche J; Holdt LM; Megens RT; Schmitt M; de Winther M; Biessen EA; Borst J; Faussner A; Weber C; Lutgens E; Gerdes N
    Thromb Haemost; 2017 Jan; 117(1):164-175. PubMed ID: 27786334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid regression of atherosclerosis: insights from the clinical and experimental literature.
    Williams KJ; Feig JE; Fisher EA
    Nat Clin Pract Cardiovasc Med; 2008 Feb; 5(2):91-102. PubMed ID: 18223541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RIP140 contributes to foam cell formation and atherosclerosis by regulating cholesterol homeostasis in macrophages.
    Lin YW; Liu PS; Adhikari N; Hall JL; Wei LN
    J Mol Cell Cardiol; 2015 Feb; 79():287-94. PubMed ID: 25528964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonlinear dynamics of early atherosclerotic plaque formation may determine the efficacy of high density lipoproteins (HDL) in plaque regression.
    Chalmers AD; Bursill CA; Myerscough MR
    PLoS One; 2017; 12(11):e0187674. PubMed ID: 29161303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan Oligosaccharides Attenuate Atherosclerosis and Decrease Non-HDL in ApoE-/- Mice.
    Yu Y; Luo T; Liu S; Song G; Han J; Wang Y; Yao S; Feng L; Qin S
    J Atheroscler Thromb; 2015; 22(9):926-41. PubMed ID: 25843117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of angiopoietin-like protein 4 protects against atherosclerosis development.
    Georgiadi A; Wang Y; Stienstra R; Tjeerdema N; Janssen A; Stalenhoef A; van der Vliet JA; de Roos A; Tamsma JT; Smit JW; Tan NS; Müller M; Rensen PC; Kersten S
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1529-37. PubMed ID: 23640487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells.
    Feig JE; Rong JX; Shamir R; Sanson M; Vengrenyuk Y; Liu J; Rayner K; Moore K; Garabedian M; Fisher EA
    Proc Natl Acad Sci U S A; 2011 Apr; 108(17):7166-71. PubMed ID: 21482781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage ABCA2 deletion modulates intracellular cholesterol deposition, affects macrophage apoptosis, and decreases early atherosclerosis in LDL receptor knockout mice.
    Calpe-Berdiel L; Zhao Y; de Graauw M; Ye D; van Santbrink PJ; Mommaas AM; Foks A; Bot M; Meurs I; Kuiper J; Mack JT; Van Eck M; Tew KD; van Berkel TJ
    Atherosclerosis; 2012 Aug; 223(2):332-41. PubMed ID: 22748276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid induces macrophage cholesterol efflux and inhibits atherosclerotic plaque formation in apoE-deficient mice.
    Zhou W; Lin J; Chen H; Wang J; Liu Y; Xia M
    Br J Nutr; 2015 Aug; 114(4):509-18. PubMed ID: 26201974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tofacitinib ameliorates atherosclerosis and reduces foam cell formation in apoE deficient mice.
    Wang Z; Wang S; Wang Z; Yun T; Wang C; Wang H
    Biochem Biophys Res Commun; 2017 Aug; 490(2):194-201. PubMed ID: 28601639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and molecular mechanisms for rapid regression of atherosclerosis: from bench top to potentially achievable clinical goal.
    Williams KJ; Feig JE; Fisher EA
    Curr Opin Lipidol; 2007 Aug; 18(4):443-50. PubMed ID: 17620862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proatherogenic macrophage activities are targeted by the flavonoid quercetin.
    Lara-Guzman OJ; Tabares-Guevara JH; Leon-Varela YM; Álvarez RM; Roldan M; Sierra JA; Londoño-Londoño JA; Ramirez-Pineda JR
    J Pharmacol Exp Ther; 2012 Nov; 343(2):296-306. PubMed ID: 22869926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggressive very low-density lipoprotein (VLDL) and LDL lowering by gene transfer of the VLDL receptor combined with a low-fat diet regimen induces regression and reduces macrophage content in advanced atherosclerotic lesions in LDL receptor-deficient mice.
    MacDougall ED; Kramer F; Polinsky P; Barnhart S; Askari B; Johansson F; Varon R; Rosenfeld ME; Oka K; Chan L; Schwartz SM; Bornfeldt KE
    Am J Pathol; 2006 Jun; 168(6):2064-73. PubMed ID: 16723719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice.
    Rinne P; Silvola JM; Hellberg S; Ståhle M; Liljenbäck H; Salomäki H; Koskinen E; Nuutinen S; Saukko P; Knuuti J; Saraste A; Roivainen A; Savontaus E
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1346-54. PubMed ID: 24790139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.